These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15726024)

  • 41. Effect of risperidone on prolactinoma--a case report.
    Mendhekar DN; Jiloha RC; Srivastava PK
    Pharmacopsychiatry; 2004 Jan; 37(1):41-2. PubMed ID: 14750048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis.
    Akkaya C; Sarandol A; Sivrioglu EY; Kotan Z; Kirli S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1535-8. PubMed ID: 16820256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
    Chen HK; Chen CK; Tzeng NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ziprasidone: efficacy and safety in patients with bipolar disorder.
    Patel NC; Keck PE
    Expert Rev Neurother; 2006 Aug; 6(8):1129-38. PubMed ID: 16893341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Galactorrhea during treatment with trimipramine. A case report.
    Wolfsperger M; Greil W
    Pharmacopsychiatry; 2005 Nov; 38(6):326-7. PubMed ID: 16342006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Profound hypothermia secondary to normal ziprasidone use.
    Gibbons GM; Wein DA; Paula R
    Am J Emerg Med; 2008 Jul; 26(6):737.e1-2. PubMed ID: 18606348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ziprasidone: a novel psychotropic with unique properties.
    Ballas C; Yang C; O'Reardon J; Ballas P; Baldassano C
    Expert Rev Neurother; 2004 Mar; 4(2):179-86. PubMed ID: 15853558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ziprasidone-induced acute dystonia.
    Mason MN; Johnson CE; Piasecki M
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract]   [Full Text] [Related]  

  • 50. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.
    Rim CL; Gitlin MJ
    J Clin Psychopharmacol; 2010 Aug; 30(4):470-1. PubMed ID: 20631570
    [No Abstract]   [Full Text] [Related]  

  • 52. [Drug-induced hyperprolactinemia and galactorrhea].
    Bozzolo M; Haefeli WE; Noll G; Lüscher TF
    Schweiz Rundsch Med Prax; 1992 Dec; 81(50):1511-3. PubMed ID: 1465520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experience with ziprasidone.
    Patel NC; Sierk P; Dorson PG; Crismon L
    J Am Acad Child Adolesc Psychiatry; 2002 May; 41(5):495. PubMed ID: 12014778
    [No Abstract]   [Full Text] [Related]  

  • 54. [Ziprasidone and dementia].
    Aakhus E
    Tidsskr Nor Laegeforen; 2004 Aug; 124(16):2155-6; author reply 2155-6. PubMed ID: 15334150
    [No Abstract]   [Full Text] [Related]  

  • 55. Galactorrhea induced by paroxetine.
    Morrison J; Remick RA; Leung M; Wrixon KJ; Bebb RA
    Can J Psychiatry; 2001 Feb; 46(1):88-9. PubMed ID: 11221498
    [No Abstract]   [Full Text] [Related]  

  • 56. Risperidone-associated galactorrhea in a male teenager.
    Gupta S; Frank B; Madhusoodanan S
    J Am Acad Child Adolesc Psychiatry; 2001 May; 40(5):504-5. PubMed ID: 11349691
    [No Abstract]   [Full Text] [Related]  

  • 57. Lithium intoxication associated with intramuscular ziprasidone in schizoaffective patients.
    Miodownik C; Hausmann M; Frolova K; Lerner V
    Clin Neuropharmacol; 2005; 28(6):295-7. PubMed ID: 16340388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Switching among antipsychotics--focus on side effects.
    Ružić K; Dadić-Hero E; Grahovac T; Sabljić V; Kosec T; Knez R
    Psychiatr Danub; 2011 Mar; 23(1):89-91. PubMed ID: 21448105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ziprasidone-related tardive dyskinesia.
    Keck ME; Müller MB; Binder EB; Sonntag A; Holsboer F
    Am J Psychiatry; 2004 Jan; 161(1):175-6. PubMed ID: 14702272
    [No Abstract]   [Full Text] [Related]  

  • 60. Ziprasidone and mania.
    Barnett MS
    J Am Acad Child Adolesc Psychiatry; 2004 Apr; 43(4):380. PubMed ID: 15187796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.